• Citer

Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-term Care Facilities: Data From the GeroCovid Vax Study.

par Virgilio, Enrico ;Trevisan, Caterina;Abbatecola, Angela;Malara, Alba;Palmieri, Annapina;Fedele, Giorgio;Stefanelli, Paola;Leone, Pasqualina;Schiavoni, Ilaria;Maggi, Stefania;Volpato, Stefano;Antonelli Incalzi, Raffaele;Onder, Graziano;GeroCovid Vax Working Group,
Référence Diabetes care, 45, 12, page (2935-2942)
Publication Publié, 2022-12

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Type 2 diabetes may affect the humoral immune response after vaccination, but data concerning coronavirus disease 19 (COVID-19) vaccines are scarce. We evaluated the impact of diabetes on antibody response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in older residents of long-term care facilities (LTCFs) and tested for differences according to antidiabetic treatment.